Congress has turned a spotlight on consulting relationships between surgeons and medical device companies. At a hearing Feb 27, the Senate Special Committee on Aging probed what the chairman, Senator Herb Kohl, called the "tangled, murky, and sometimes conflicting financial relationships" between industry and physicians.
